PhRMA names next CEO; Pierre Fabre takes third swing at Ebvallo approval

🇺🇸 BioPharma Dive (US) — 2026-09-30

PhRMA has named a former congressman as its next CEO, succeeding prominent lobbyist Steve Ubl. The article also notes Pierre Fabre’s renewed effort to secure approval for Ebvallo and says recent buyouts benefited Mirum and AbbVie.

A former congressman will take over for prominent lobbyist Steve Ubl. Elsewhere, recent buyout deals paid dividends for Mirum and AbbVie.

Politics Markets Deals Health PhRMA CEO appointment pharmaceuticals Ebvallo buyouts biotech

Read original source →

Andhra Pradesh pitches investment opportunities to Maharashtra companies
The Hindu — 2026-09-30
Indigenous operators now produce 50% of Nigeria’s oil
Vanguard Nigeria — 2026-09-30
European Commission suggests creating communication system for EU civil defense agencies
TASS — 2026-09-30
Y’a-t-il le feu au lac chez Edouard Philippe ?
Politico Europe — 2026-09-30
FG, DisCos plan 24/7 power supply zones
Vanguard Nigeria — 2026-09-30
Raitha Sangha seeks import duty to protect local red gram growers
The Hindu — 2026-09-30

PhRMA names next CEO; Pierre Fabre takes third swing at Ebvallo approval

AI Summary

Related Articles

Andhra Pradesh pitches investment opportunities to Maharashtra companies

Indigenous operators now produce 50% of Nigeria’s oil

European Commission suggests creating communication system for EU civil defense agencies

Y’a-t-il le feu au lac chez Edouard Philippe ?

FG, DisCos plan 24/7 power supply zones

Raitha Sangha seeks import duty to protect local red gram growers